These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Conversion from tacrolimus to microemulsion formulation of cyclosporine in pediatric liver transplantation. Alberti D, Reding R, Otte JB, Falchetti D, Rigamonti W, Caccia G, Sokal E, de Ville de Goyet J. Transplant Proc; 1998 Aug; 30(5):1858-60. PubMed ID: 9723310 [No Abstract] [Full Text] [Related]
3. Disappearance of diabetes mellitus after conversion from FK 506 to Neoral in two liver transplanted patients. Lagget M, Marzano A, Actis GC, Leone N, Ciancio A, Salizzoni M, Rizzetto M. Transplant Proc; 1998 Aug; 30(5):1863-4. PubMed ID: 9723312 [No Abstract] [Full Text] [Related]
11. Frequency of switch from cyclosporine to FK 506 before and after Neoral use in pediatric liver transplantation. Gridelli B, Colledan M, Lucianetti A, Ulla L, Riva S, Segalin A, Fassati LR, Torre G. Transplant Proc; 1998 Aug; 30(5):1861-2. PubMed ID: 9723311 [No Abstract] [Full Text] [Related]
13. Conversion and pharmacokinetic studies of a microemulsion formulation of cyclosporine in pediatric liver transplant patients. D'Agostino D, Gimenez M, Yamaguchi B, Glancszpigel R, Vinuesa F, Gamba M, Ciardullo M, de Santibaes E. Transplantation; 1996 Oct 27; 62(8):1068-71. PubMed ID: 8900303 [Abstract] [Full Text] [Related]
14. Successful reconversion from tacrolimus to cyclosporine A Neoral in pediatric liver recipients. Melter M, Rodeck B, Kardorff R, Hoyer PF, Maibücher A, Brodehl J. Transplant Proc; 1996 Aug 27; 28(4):2276-8. PubMed ID: 8769224 [No Abstract] [Full Text] [Related]
16. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus. Levy G, Grazi GL, Sanjuan F, Wu Y, Mühlbacher F, Samuel D, Friman S, Jones R, Cantisani G, Villamil F, Cillo U, Clavien PA, Klintmalm G, Otto G, Pollard S, McCormick PA. Liver Transpl; 2006 Oct 27; 12(10):1464-72. PubMed ID: 17004259 [Abstract] [Full Text] [Related]
17. Results of conversion from Sandimmune to Neoral in stable pediatric liver transplant recipients after two years. Dunn SP, Falkenstein K, Pierson A, Cooney GF. Transplant Proc; 1998 Aug 27; 30(5):1962-3. PubMed ID: 9723353 [No Abstract] [Full Text] [Related]
18. Conversion from the conventional cyclosporine formulation (Sandimmune) to a new oral microemulsion (Neoral) in stable liver transplant patients. Dibo-Cohen JM, Conort O, Conti F, Bernard D, Hazebroucq G, Calmus Y. Transplant Proc; 1998 Aug 27; 30(5):1857. PubMed ID: 9723309 [No Abstract] [Full Text] [Related]